Analyst Michael Ryskin from Bank of America Securities reiterated a Sell rating on Align Tech and decreased the price target to $150.00 from $195.00.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Michael Ryskin has given his Sell rating due to a combination of factors impacting Align Tech’s performance. The company reported disappointing results in the second quarter, with sales and case volumes falling short of expectations. This underperformance was attributed to macroeconomic issues, such as tariff-related challenges in the US and Europe, which have led to a decline in dental visits and orthodontic case starts.
Additionally, Align Tech’s guidance for the third quarter and fiscal year 2025 has been revised downward, indicating potential ongoing struggles. The company’s ambitious growth targets for 2026 also appear increasingly unrealistic given the current performance trends. These factors, coupled with a competitive market environment, have led to a reduction in the price objective to $150 and a reiteration of the Underperform rating.
ALGN’s price has also changed slightly for the past six months – from $225.360 to $203.570, which is a -9.67% drop .